Dow Jones

38 686,32

0,00%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Advanced Accelerator Applications S.A. ADS (delisted) (AAAP)
Advanced Accelerator Applications S.A. ADS (delisted) (AAAP) Actualités

AAAP

ADVANCED ACCELERATOR APPLICATION (AAAP)

Advanced Accelerator Applications S.A. ADS (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:AAAP

1 2 3 4 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
26/02/2019	20h06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
03/12/2018	09h00	GlobeNewswire Inc.	Advanced Accelerator Applications signs exclusive option and license agreement with FUJIFILM Toyama Chemical to develop and c...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
12/02/2018	15h18	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
12/02/2018	13h00	GlobeNewswire Inc.	Advanced Accelerator Applications Signs Exclusive License Agreement with Cancer Targeted Technology to Develop CTT1057, an F-...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
09/02/2018	19h09	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	22h24	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	22h24	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	22h24	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	22h21	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	22h05	GlobeNewswire Inc.	Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
01/02/2018	15h02	Edgar (US Regulatory)	(25)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
26/01/2018	18h00	GlobeNewswire Inc.	Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendoc...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
22/01/2018	14h00	GlobeNewswire Inc.	Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
07/12/2017	13h16	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
07/12/2017	13h00	GlobeNewswire Inc.	Advanced Accelerator Applications Announces Commencement of Novartis Tender Offer	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
07/12/2017	12h05	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
05/12/2017	22h20	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
05/12/2017	22h00	GlobeNewswire Inc.	Advanced Accelerator Applications Board of Directors Recommends $3.9 Billion All Cash Tender Offer by Novartis	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
24/11/2017	12h01	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
17/11/2017	13h39	GlobeNewswire Inc.	Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
31/10/2017	00h46	Dow Jones News	ADRs End Mostly Higher; Advanced Accelerator Applications, Braskem Trade Actively	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
30/10/2017	14h00	Dow Jones News	Novartis to Pay $3.9 Billion for Radio-Pharmaceuticals Firm -- Update	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
30/10/2017	08h08	Dow Jones News	Novartis to Buy Advanced Accelerator Applications for $3.9 Billion	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
30/10/2017	07h00	GlobeNewswire Inc.	Advanced Accelerator Applications Announces $3.9 Billion All Cash Proposed Tender Offer by Novartis	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
29/09/2017	15h16	GlobeNewswire Inc.	Advanced Accelerator Applications Announces European Approval of Lutetium (177Lu) Oxodotreotide (Lutathera®) for Gastroenter...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
06/09/2017	17h03	GlobeNewswire Inc.	CORRECTING and REPLACING -- Advanced Accelerator Applications S.A.	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
06/09/2017	13h00	GlobeNewswire Inc.	Advanced Accelerator Applications and FUJIFILM RI Pharma, Co., LTD Announce First Patient in Bridging Study in Japan for Lute...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
31/08/2017	13h00	GlobeNewswire Inc.	Advanced Accelerator Applications Reports 32% Sales Growth for Second Quarter 2017	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
28/08/2017	16h08	GlobeNewswire Inc.	Advanced Accelerator Applications Announces New Prescription Drug User Fee Act (PDUFA) date of January 26, 2018, for Lutetium...	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)
27/07/2017	13h00	GlobeNewswire Inc.	Advanced Accelerator Applications Completes Resubmission of NDA for Lutetium Lu 177 Dotatate (Lutathera®) to FDA	NASDAQ:AAAP	Advanced Accelerator Applications S.A. ADS (delisted)